American Century Companies Inc. Has $135.48 Million Holdings in STERIS plc $STE

American Century Companies Inc. raised its holdings in STERIS plc (NYSE:STE) by 0.6% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 547,521 shares of the medical equipment provider’s stock after buying an additional 3,136 shares during the period. American Century Companies Inc.’s holdings in STERIS were worth $135,479,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in STE. Steigerwald Gordon & Koch Inc. acquired a new position in shares of STERIS during the 3rd quarter worth approximately $25,000. Spurstone Advisory Services LLC acquired a new stake in STERIS during the 2nd quarter valued at $29,000. Cloud Capital Management LLC bought a new position in STERIS during the third quarter worth $29,000. Geneos Wealth Management Inc. increased its holdings in shares of STERIS by 416.0% in the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 104 shares during the last quarter. Finally, TruNorth Capital Management LLC bought a new position in shares of STERIS in the third quarter valued at about $37,000. 94.69% of the stock is owned by institutional investors and hedge funds.

STERIS Price Performance

STE stock opened at $252.36 on Monday. The company’s 50-day moving average price is $255.83 and its two-hundred day moving average price is $251.77. The firm has a market cap of $24.75 billion, a P/E ratio of 35.20 and a beta of 1.05. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44.

STERIS (NYSE:STE) last posted its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. STERIS’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter last year, the business posted $2.32 EPS. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be issued a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, February 17th. STERIS’s dividend payout ratio (DPR) is currently 35.15%.

Analysts Set New Price Targets

Several analysts recently commented on the stock. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a report on Friday, January 9th. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Saturday, February 14th. Six equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.